Cargando…
Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
BACKGROUND: The literature suggests patient characteristics and higher opioid doses and long-term duration are associated with problematic opioid behaviours but no one study has examined the role of all these factors simultaneously in a long-term prospective cohort study. METHODS: Five-year, communi...
Autores principales: | Campbell, Gabrielle, Noghrehchi, Firouzeh, Nielsen, Suzanne, Clare, Phillip, Bruno, Raimondo, Lintzeris, Nicholas, Cohen, Milton, Blyth, Fiona, Hall, Wayne, Larance, Briony, Hungerford, Phillip, Dobbins, Timothy, Farrell, Michael, Degenhardt, Louisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700907/ https://www.ncbi.nlm.nih.gov/pubmed/33294810 http://dx.doi.org/10.1016/j.eclinm.2020.100592 |
Ejemplares similares
-
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018
por: Degenhardt, Louisa, et al.
Publicado: (2021) -
Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study
por: Campbell, Gabrielle, et al.
Publicado: (2014) -
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018) -
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020) -
Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)